Patents by Inventor Harlan Chapman

Harlan Chapman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
    Publication number: 20060024659
    Abstract: A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided.
    Type: Application
    Filed: February 24, 2004
    Publication date: February 2, 2006
    Inventors: Mark Becker, Harlan Chapman, Tomas Cihlar, Eugene Eisenberg, Gong-Xin He, Michael Kernan, William Lee, Ernest Prisbe, John Rohloff, Mark Sparacino
  • Prodrugs of phosphonate nucleotide analogues
    Publication number: 20050159392
    Abstract: A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided.
    Type: Application
    Filed: January 6, 2005
    Publication date: July 21, 2005
    Inventors: Mark Becker, Harlan Chapman, Tomas Cihlar, Eugene Eisenberg, Gong-Xin He, Michael Kernan, William Lee, Ernest Prisbe, John Rohloff, Mark Sparacino
  • Prodrugs of phosphonate nucleotide analogues
    Publication number: 20050124585
    Abstract: A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided.
    Type: Application
    Filed: January 6, 2005
    Publication date: June 9, 2005
    Inventors: Mark Becker, Harlan Chapman, Tomas Cihlar, Eugene Eisenberg, Gong-Xin He, Michael Kernan, William Lee, Ernest Prisbe, John Rohloff, Mark Sparacino
  • Prodrugs of phosphonate nucleotide analogues
    Publication number: 20050124583
    Abstract: A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided.
    Type: Application
    Filed: January 6, 2005
    Publication date: June 9, 2005
    Inventors: Mark Becker, Harlan Chapman, Tomas Clhlar, Eugene Elsenberg, Gong-Xin He, Michael Kernan, William Lee, Ernest Prisbe, John Rohloff, Mark Sparacino
  • Prodrugs of phosphonate nucleotide analogues
    Publication number: 20050124584
    Abstract: A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided.
    Type: Application
    Filed: January 6, 2005
    Publication date: June 9, 2005
    Inventors: Mark Becker, Harlan Chapman, Tomas Cihlar, Eugene Eisenberg, Gong-Xin He, Michael Kernan, William Lee, Ernest Prisbe, John Rohloff, Mark Sparacino
  • Prodrugs of phosphonate nucleotide analogues
    Publication number: 20050009043
    Abstract: A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided.
    Type: Application
    Filed: March 11, 2004
    Publication date: January 13, 2005
    Inventors: Mark Becker, Harlan Chapman, Tomas Cihlar, Eugene Eisenberg, Gong-Xin He, Michael Kernan, William Lee, Ernest Prisbe, John Rohloff, Mark Sparacino